No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC)

Epidermal growth factor receptor (EGFR) is usually expressed in squamous cell anal carcinoma (SCAC) and anti-EGFR agents could represent a valid treatment strategy, also considering that KRAS and BRAF mutations are rare events in this type of cancer. However, no data are available on NRAS status in...

Descripción completa

Detalles Bibliográficos
Autores principales: Capelli, Laura, Casadei Gardini, Andrea, Scarpi, Emanuela, Frassineti, Giovanni Luca, Saragoni, Luca, Puccetti, Maurizio, Scartozzi, Mario, Giannini, Massimo, Tamberi, Stefano, Corbelli, Jody, Ulivi, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122846/
https://www.ncbi.nlm.nih.gov/pubmed/27886225
http://dx.doi.org/10.1038/srep37621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122846/
https://www.ncbi.nlm.nih.gov/pubmed/27886225
http://dx.doi.org/10.1038/srep37621

Ejemplares similares